STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) Return on equity
STERIS plc's return on equity over the twelve months to 30 June 2026 was 11.4%, up 0.0 percentage points from fiscal 2026 (11.3%). Over the past ten years it has ranged from 1.69% (fiscal 2023) to 12.8% (fiscal 2015); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of −15.3% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | 11.3% | 1.82 |
| FY2025 | 9.51% | 3.41 |
| FY2024 | 6.10% | 4.41 |
| FY2023 | 1.69% | (2.98) |
| FY2022 | 4.67% | (6.20) |
| FY2021 | 10.9% | (1.48) |
| FY2020 | 12.4% | 2.86 |
| FY2019 | 9.49% | (0.16) |
| FY2018 | 9.65% | 5.89 |
| FY2017 | 3.76% | (1.63) |
Against its own ten years
Low 1.69%
High 12.8%
Ten-year median
9.50%
Current reading's percentile
83
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 38.5% |
| GEHC GE HealthCare Technologies Inc. compare | 19.2% |
| PEN Penumbra, Inc. compare | 11.4% |
| STE STERIS plc | 11.4% |
| PHG Koninklijke Philips N.V. compare | 10.2% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 6.41% |
| BIO Bio-Rad Laboratories, Inc. compare | 3.11% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 3.11% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −15.3% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement